Kaila Jane Frymire Harris, MS, CF-SLP | |
1635 Aurora Ct Fl 6, Aurora, CO 80045-2541 | |
(720) 848-0000 | |
Not Available |
Full Name | Kaila Jane Frymire Harris |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1635 Aurora Ct Fl 6, Aurora, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447924527 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | PSLP.0000816 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kaila Jane Frymire Harris, MS, CF-SLP 84 Ferdinand St, Melrose, MA 02176-1155 Ph: (612) 220-6700 | Kaila Jane Frymire Harris, MS, CF-SLP 1635 Aurora Ct Fl 6, Aurora, CO 80045-2541 Ph: (720) 848-0000 |
News Archive
Scientists at The Scripps Research Institute have developed chemical compounds that can make key modifications to common sugar molecules ("glycans"), which are found on the surface of all cells in our body. The new study presents powerful new tools for studying these molecules' function, for example in cell signaling and immunity, and for investigating new treatments for chronic inflammation, autoimmune diseases, cancer metastasis, and related conditions.
In this UNFPA opinion piece, Babatunde Osotimehin, U.N. under-secretary-general and UNFPA executive director, and Sharon Camp, president and CEO of the Guttmacher Institute, reflect on last month's London Summit on Family Planning, where "leaders from 18 African countries made unprecedented commitments - financially and politically - to strengthen their family planning programs,"
NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 trial of its HyperAcute immunotherapy in pancreatic cancer. Pancreatic cancer is highly lethal and is currently an area of very significant unmet medical need. The SPA is a written agreement between NewLink as the trial sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of a Phase 3 trial to be used in support of a Biologic License Application (BLA).
Illumina, Inc. today announced the launch of the VeriSeqâ„¢ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing, including CE-IVD marked library prep and analysis software, which enables laboratories in the European Union to bring efficient, highly accurate NIPT in-house.
› Verified 3 days ago
Miss Elizabeth Frances Peterson, M.A.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 S Parker Rd Ste 336, Aurora, CO 80014 Phone: 303-330-3309 Fax: 303-862-9770 | |
Rebecca Aragon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Kristina Hess, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Geneva St, Aurora, CO 80010 Phone: 303-364-9311 | |
Elizabeth Marie Cuadrado, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1635 Aurora Court, 6th Floor, Ms F737, Aurora, CO 80045 Phone: 954-735-6000 | |
Cheryl Anselmo, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Box 030, Aurora, CO 80045 Phone: 720-777-6085 | |
Mrs. Melanie Lynn Wiseman, M.S. SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2851 S Parker Rd Ste 570, Aurora, CO 80014 Phone: 303-888-4840 | |
Chloe Mizusawa, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10100 E 13th Ave, Aurora, CO 80010 Phone: 303-366-2671 |